SummaryOrforglipron, a new daily pill, may be more effective than existing oral treatments for weight loss and blood sugar control than semaglutide, according to a recent clinical trial. Participants taking orforglipron lost around up to eight kilograms on average, compared to about five kilograms with semaglutide